This inventor holds 43 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Microfluidic Technology. Top assignees: Illumina Corporation, Novartis Ag, Novartis Corporation. Active years: 1993-2026.
Location History:
- Medford, MA (US) (1993)
- Basel, CH (1994 - 1998)
- Wellesley, MA (US) (2000)
- Wellesley Hills, MA (US) (1998 - 2001)
- Framingham, MA (US) (2001)
- San Diego, CA (US) (2000 - 2021)
- Del Mar, CA (US) (2021 - 2024)
Company Filing History:
27 out of 1,211 
8 out of 3,973 
3 out of 166 
Years Active: 1993-2026
Areas of Expertise:
Title: Innovations by Steven Mark Barnard in Microfluidic Systems
Introduction
Steven Mark Barnard is a prolific inventor based in San Diego, CA, with an impressive portfolio of 39 patents to his name. His work primarily focuses on innovations in microfluidic systems, presenting novel methods and devices that significantly enhance molecular detection and analysis.
Latest Patents
Among his latest patents is a groundbreaking method for mixing in a microfluidic system. This invention introduces a microfluidic device that features a flow cell with an inlet port, an outlet port, and a flow channel. The flow channel is designed to accommodate an analyte of interest along with various reagents necessary for molecular analysis. The unique aspect of this device lies in its integrated mixing mechanisms, including electrothermal, active mechanical, and vibrational mixing devices, aimed at accelerating the reactions and enhancing the efficacy of the analysis.
Another notable patent focuses on substrates that possess nano-patterning capabilities. These substrates comprise a functionalizable layer, a polymer layer with micro or nano-scale patterns, and a backing layer. They can be produced using a roll-to-roll continuous process via room-temperature UV nano-embossing. Such substrates have broad applications, particularly in the development of flow cells and devices intended for the analysis of biological molecules.
Career Highlights
Steven Barnard has contributed significantly to the field of biotechnology through his associations with esteemed companies like Illumina Corporation and Novartis AG. His expertise in microfluidic technologies has made substantial impacts on processes related to genetic research and pharmaceutical development.
Collaborations
Throughout his career, Barnard has collaborated with notable peers, including M Shane Bowen and Joseph Berger. These collaborations have further enriched his innovative contributions to the field.
Conclusion
Steven Mark Barnard’s extensive portfolio and innovative patents underscore his role as a key figure in advancing microfluidic technologies. His contributions continue to drive forward the capabilities of molecular analysis, paving the way for new applications in the scientific community.